Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Resynchronization Therapy Compromised By ICD Backup, Saxon Tells NASPE

This article was originally published in The Gray Sheet

Executive Summary

Resynchronization therapy with an implantable defibrillator backup undermines the salutary effect of bi-ventricular pacing for congestive heart failure, according to Leslie Saxon, MD, University of California at San Francisco.[Editors' note: Please see the attached June 6 letter to "The Gray Sheet" from Saxon commenting on the context of her presentation at NASPE. The presentation, Saxon says, should not have been reported literally.]

You may also be interested in...



Cardiologist Groups Guard Medicare ICD Payments From Physician Fee Cuts

Cardiologists are trying to guarantee that projected cost increases associated with internal cardioverter defibrillation implant procedures will not be offset by further cuts in Medicare payments to physicians

Cardiologist Groups Guard Medicare ICD Payments From Physician Fee Cuts

Cardiologists are trying to guarantee that projected cost increases associated with internal cardioverter defibrillation implant procedures will not be offset by further cuts in Medicare payments to physicians

Medtronic InSync ICD Gains Panel Support In Tiebreaking 6-5 Vote

The recommended post-market requirement for Medtronic's InSync ICD and its pacing counterpart suggests that companies that conduct pivotal studies with a small number of patients will be expected to follow up with a large trial

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel